New Delhi [India], May 29 (ANI): Delhi received a fresh stock of COVID-19 vaccine that includes 48,890 doses of Covaxin and 83,970 doses of Covishield from the Centre, said Aam Aadmi Party (AAP) MLA Atishi on Saturday.
New Delhi [India], May 29 (ANI): As the Delhi government has rolled out global tenders for procuring COVID-19 vaccines, Delhi Chief Minster Arvind Kejriwal has expressed his apprehensions regarding the procurement process, saying that most of the vaccine manufacturers globally prefers to tal
New Delhi [India], May 29 (ANI): As some states are engaged in floating global tenders for covid-19 vaccine supply, the Central government has so far provided, both through the free of cost category and through direct state procurement category, 22,77,62,450 vaccine doses to the states an
New Delhi [India], May 29 (ANI): The Delhi government has floated a Global Expression of Interest (EOI) for procurement of 1 crore doses of Covid-19 vaccines on an urgent basis.
Washington [US], May 29 (ANI): The US government on Friday (local time) has redirected orders of critical vaccine manufacturing supplies, which will allow India to make over 20 million additional doses of AstraZeneca COVID-19 vaccines.
New Delhi [India], May 29 (ANI): The GST Council at its 43rd meeting held on Friday recommended full exemption from IGST on a number of specified COVID-19 related goods such as medical oxygen, oxygen concentrators and other oxygen storage and transportation equipment, certain diagnostic m
New Delhi [India], May 28 (ANI): Congress leader Priyanka Gandhi Vadra on Friday questioned the Centre that why is it dependent on other countries for COVID vaccines when India is of the biggest exporters of vaccines in the world.
New Delhi [India], May 28 (ANI): Dr. Reddy's Laboratories on Friday said that it has not entered into any partnership for supplying Sputnik V COVID-19 vaccine to residential associations and has not authorised any third party or intermediary to supply the vaccine on its behalf in India.
New Delhi [India], May 28 (ANI): Amid reports of shortage of its COVID-19 vaccine in the country, Bharat Biotech on Friday said that the timeline for manufacturing, testing, and release for a batch of Covaxin is approximately 120 days, depending on the technology framework and regulatory
Hyderabad (Telangana) [India], May 28 (ANI): Indian Immunologicals Limited (IIL) has partnered with Hyderabad-based Bharat Biotech to manufacture drug substance for 'Covaxin' to ramp up the production of the COVID-19 vaccine.
New Delhi [India], May 28 (ANI): Administering two different COVID-19 vaccines, specially those with similar underlying platform, is still under research and supply constraints have to be resolved so that people can take their vaccine doses on time, experts have said.